Financial Statements — QTEXW
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 2.13 | 3.55 | 3.32 | 14.15 | 4.36 |
| Inventory | 0.71 | 0.38 | -- | -- | -- |
| Total Current Assets | 3.26 | 8.08 | 9.32 | 19.44 | 5.58 |
| Property, Plant & Equipment | 0.53 | 0.44 | -- | -- | -- |
| Total Non-current Assets | 1.20 | 1.34 | 1.52 | 1.31 | 0.31 |
| Total Assets | 4.45 | 9.42 | -- | -- | -- |
| Total Current Liabilities | 2.83 | 3.62 | 2.27 | 1.91 | 14.96 |
| Total Non-current Liabilities | 0.35 | 0.46 | 1.02 | 1.08 | 0.50 |
| Total Liabilities* | 3.17 | 4.08 | -- | -- | -- |
| Retained Earnings | -- | -- | (44.92) | (32.26) | (20.13) |
| Total Stockholder Equity | 1.28 | 5.34 | 7.55 | 17.75 | (9.56) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 0.29 | -- | -- | -- | -- |
| Cost of Revenue | 0.29 | -- | -- | -- | -- |
| Gross Profit | 0.00 | -- | -- | -- | -- |
| Research & Development | 3.64 | 3.27 | -- | -- | -- |
| Selling, General & Admin | 3.15 | 2.18 | -- | 2.94 | 1.21 |
| Total Operating Expenses | 7.24 | -- | -- | -- | -- |
| Operating Income | (7.23) | (5.81) | (6.33) | (8.01) | (2.56) |
| Pretax Income | (6.40) | (6.24) | (5.85) | (3.47) | (8.29) |
| Net Income | (6.40) | (6.24) | -- | -- | (8.29) |
| Basic EPS | (0.24) | (0.38) | (0.54) | (0.54) | (3.11) |
| Diluted EPS | (0.24) | (0.38) | (0.54) | (0.54) | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (5.09) | (4.86) | (4.65) | (1.96) | (2.33) |
| Capital Expenditures | 0.10 | 0.00 | -- | -- | -- |
| Free Cash Flow* | (5.19) | (4.86) | -- | -- | -- |
| Investing Cash Flow | 0.57 | (1.39) | 1.72 | (5.01) | (0.90) |
| Financing Cash Flow | 1.52 | 4.76 | (0.20) | (0.15) | 7.11 |
* Derived from reported values
